Plantae Extracts Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 08-07-2024
- Paid Up Capital ₹ 0.10 M
as on 08-07-2024
- Company Age 17 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2022)
- Profit 272.20%
(FY 2022)
- Net Worth 26.00%
(FY 2022)
- Total Assets 33.47%
(FY 2022)
About Plantae Extracts
The Corporate was formerly known as V & V Foods Private Limted. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Savita Mittal and Niranjan Mittal serve as directors at the Company.
- CIN/LLPIN
U15122DL2007PTC169522
- Company No.
169522
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Oct 2007
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
West Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Plantae Extracts?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Niranjan Mittal  | Additional Director | 02-Sep-2013 | Current |
| Savita Mittal | Additional Director | 02-Sep-2013 | Current |
Financial Performance of Plantae Extracts.
Plantae Extracts Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 272.2% increase in profit. The company's net worth Soared by an impressive increase of 26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Plantae Extracts?
In 2020, Plantae Extracts had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ambe Ns Agro Products Private LimitedActive 11 years 6 monthsSavita Mittal and Niranjan Mittal are mutual person
Ambe Ns Pharma Private LimitedActive 11 months 1 daySavita Mittal and Niranjan Mittal are mutual person
- Mittal Investment Management Private LimitedActive 13 years 8 months
Savita Mittal and Niranjan Mittal are mutual person
- Ns3 Computech Private LimitedActive 11 years 4 months
Savita Mittal and Niranjan Mittal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Plantae Extracts?
Unlock and access historical data on people associated with Plantae Extracts, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Plantae Extracts, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Plantae Extracts's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
